I understand that Rush, Chicago will partake in upcoming Trastuzumab-MCC-DM1 trial(s). Potent toxin is delivered via Herceptin to kill cancer cells, side effects of drug favors that of non-targeted chemo therapy.
More detailed information can be obtained from Genentech by contacting
Michele Fernandes fernandes.michele@gene.com